WO2002049607A3 - Flavoured oral drug delivery system - Google Patents

Flavoured oral drug delivery system Download PDF

Info

Publication number
WO2002049607A3
WO2002049607A3 PCT/IB2001/002263 IB0102263W WO0249607A3 WO 2002049607 A3 WO2002049607 A3 WO 2002049607A3 IB 0102263 W IB0102263 W IB 0102263W WO 0249607 A3 WO0249607 A3 WO 0249607A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
delivery system
oral drug
flavoured
flavoured oral
Prior art date
Application number
PCT/IB2001/002263
Other languages
French (fr)
Other versions
WO2002049607A2 (en
Inventor
Jerome Barra
Original Assignee
Firmenich & Cie
Jerome Barra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firmenich & Cie, Jerome Barra filed Critical Firmenich & Cie
Publication of WO2002049607A2 publication Critical patent/WO2002049607A2/en
Publication of WO2002049607A3 publication Critical patent/WO2002049607A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention discloses a flavoured oral drug delivery system susceptible of masking the unpleasant taste of an active substance to be delivered during a delayed, sustained, or immediate release, and a process for the preparation of such a system.
PCT/IB2001/002263 2000-12-20 2001-11-27 Flavoured oral drug delivery system WO2002049607A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IBPCT/IB00/01934 2000-12-20
IB0001934 2000-12-20

Publications (2)

Publication Number Publication Date
WO2002049607A2 WO2002049607A2 (en) 2002-06-27
WO2002049607A3 true WO2002049607A3 (en) 2003-03-20

Family

ID=11004014

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/002263 WO2002049607A2 (en) 2000-12-20 2001-11-27 Flavoured oral drug delivery system

Country Status (1)

Country Link
WO (1) WO2002049607A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003201161B2 (en) * 2002-01-15 2008-02-28 Ucb Farchim S.A. Formulations
EP1689245A2 (en) * 2003-12-01 2006-08-16 Hill's Pet Nutrition Inc. Palatability enhanced composition and method for animal consumption
AU2006269937B2 (en) 2005-07-19 2011-02-10 Mars Incorporated Aroma composition and method
US20070077300A1 (en) 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
CN100386086C (en) * 2006-03-09 2008-05-07 山东山大康诺制药有限公司 Dispersed compound tablet of glycyrrhizic acid and glycyrrhizinate and its preparing process
EP2065038A1 (en) 2007-11-30 2009-06-03 Pharnext New therapeutic approaches for treating Charcot-Marie-Tooth disease
EP2263665A1 (en) 2009-06-02 2010-12-22 Pharnext New compositions for treating CMT and related disorders
US9393241B2 (en) 2009-06-02 2016-07-19 Pharnext Compositions for treating CMT and related disorders
JP6180722B2 (en) * 2012-10-31 2017-08-16 キリンビバレッジ株式会社 Taste improver of triterpene or its glycoside
CN105473131A (en) * 2013-06-05 2016-04-06 法奈克斯公司 Stable oral solutions for combined API
FR3039990B1 (en) * 2015-08-10 2018-07-06 Rhodia Operations ENCAPSULATION METHOD
US10383870B2 (en) 2016-06-10 2019-08-20 Pharnext Early treatment of CMT disease

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184999A2 (en) * 1984-12-12 1986-06-18 Boehringer Mannheim Italia S.P.A. Granular dietetic products based on amino acids and process for their preparation
US4950654A (en) * 1988-08-12 1990-08-21 Basf Aktiengesellschaft Hydrophilic theophylline powder formulation and its preparation
EP0422290A1 (en) * 1989-10-09 1991-04-17 Eli Lilly And Company Novel drug delivery system
WO1994025006A1 (en) * 1993-04-26 1994-11-10 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
US5846557A (en) * 1996-03-20 1998-12-08 Cumberland Packing Corporation Chewing gum containing cough suppressing agent
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
WO2000025606A1 (en) * 1998-11-04 2000-05-11 Firmenich Sa Solid delivery systems for aroma ingredients

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184999A2 (en) * 1984-12-12 1986-06-18 Boehringer Mannheim Italia S.P.A. Granular dietetic products based on amino acids and process for their preparation
US4950654A (en) * 1988-08-12 1990-08-21 Basf Aktiengesellschaft Hydrophilic theophylline powder formulation and its preparation
EP0422290A1 (en) * 1989-10-09 1991-04-17 Eli Lilly And Company Novel drug delivery system
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
WO1994025006A1 (en) * 1993-04-26 1994-11-10 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
US5846557A (en) * 1996-03-20 1998-12-08 Cumberland Packing Corporation Chewing gum containing cough suppressing agent
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
WO2000025606A1 (en) * 1998-11-04 2000-05-11 Firmenich Sa Solid delivery systems for aroma ingredients

Also Published As

Publication number Publication date
WO2002049607A2 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
WO2004070017A3 (en) Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
BE2011C013I2 (en)
WO2000042992A3 (en) Compositions and methods for mucosal delivery
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
WO2001078683A3 (en) Sustained release formulations comprising growth hormone
WO2004009445A3 (en) Packaging and dispensing of rapid dissolve dosage form
WO2002070438A3 (en) Compositions for delivering bisphosphonates
DE60202477D1 (en) DEVICE FOR ADMINISTERING A SUBSTANCE
WO2003082247A3 (en) Drug microparticles
AU1227899A (en) Osmotic medicament releasing system
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
YU84703A (en) Aripiprazole oral solution
ATE211385T1 (en) FORMS OF APPLICATION FOR THE TREATMENT OF MALE ERECTILE DYSFUNCTION
WO2004089336A3 (en) Drug delivery systems comprising an encapsulated active ingredient
WO1998026780A3 (en) Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
WO2002047607A3 (en) Process for the preparation of a fast dissolving dosage form
WO2002094774A3 (en) Oxcarbazepine dosage forms
WO2002049607A3 (en) Flavoured oral drug delivery system
WO2003000172A3 (en) Methods, pharmaceutical compositions, oral compositions, filters and tobacco products for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject
WO2002015959A3 (en) Compounds and compositions for delivering active agents
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
WO2002055061A3 (en) Method of producing porous tablets with improved dissolution properties
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
WO2005039481A3 (en) Oral drug delivery system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): IL IN JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP